The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline
Open accessAbstract
PURPOSE: To systematically review the evidence for the radiotherapeutic and surgical management of patients newly diagnosed with intraparenchymal brain metastases. METHODS AND MATERIALS: Key clinical questions to be addressed in this evidence-based Guideline were identified. Fully published randomized controlled trials dealing with the management of newly diagnosed intraparenchymal brain metastases were searched systematically and reviewed. The U.S. Preventative Services Task Force levels of evidence were used to classify various options of management. RESULTS: The choice of management in patients with newly diagnosed single or multiple brain metastases depends on estimated prognosis and the aims of treatment (survival, local treated lesion control, distant brain control, neurocognitive preservation). Single brain metastasis and good prognosis (expected survival 3 months or more): For a single brain metastasis larger than 3 to 4 cm and amenable to safe complete resection, whole brain radiotherapy (WBRT) and surgery (level 1) should be considered. Another alternative is surgery and radiosurgery/radiation boost to the resection cavity (level 3). For single metastasis less than 3 to 4 cm, radiosurgery alone or WBRT and radiosurgery or WBRT and surgery (all based on level 1 evidence) should be considered. Another alternative is surgery and radiosurgery or radiation boost to the resection cavity (level 3). For single brain metastasis (less than 3 to 4 cm) that is not resectable or incompletely resected, WBRT and radiosurgery, or radiosurgery alone should be considered (level 1). For nonresectable single brain metastasis (larger than 3 to 4 cm), WBRT should be considered (level 3). Multiple brain metastases and good prognosis (expected survival 3 months or more): For selected patients with multiple brain metastases (all less than 3 to 4 cm), radiosurgery alone, WBRT and radiosurgery, or WBRT alone should be considered, based on level 1 evidence. Safe resection of a brain metastasis or metastases causing significant mass effect and postoperative WBRT may also be considered (level 3). Patients with poor prognosis (expected survival less than 3 months): Patients with either single or multiple brain metastases with poor prognosis should be considered for palliative care with or without WBRT (level 3). It should be recognized, however, that there are limitations in the ability of physicians to accurately predict patient survival. Prognostic systems such as recursive partitioning analysis, and diagnosis-specific graded prognostic assessment may be helpful. CONCLUSIONS: Radiotherapeutic intervention (WBRT or radiosurgery) is associated with improved brain control. In selected patients with single brain metastasis, radiosurgery or surgery has been found to improve survival and locally treated metastasis control (compared with WBRT alone).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,135
Gaspar, L., Scott, C., Rotman, M., Asbell, S., Phillips, T., Wasserman, T., McKenna, W. G., & Byhardt, R. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,544
Self-citationChang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
Self-citationAndrews, D. W., Scott, C. B., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J.-P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16250-8 · Cited by 2,417
Self-citationAoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Kocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain: A Randomized Trial
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. (1998) · JAMA · doi:10.1001/jama.280.17.1485 · Cited by 1,915
Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery
Vecht, C. J., Haaxma‐Reiche, H., Noordijk, E. M., Padberg, G. W., Voormolen, J. H. C., Hoekstra, F. H., Tans, J. T. J., Lambooij, N., Metsaars, J. A. L., Wattendorff, A. R., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330605 · Cited by 1,049
Sperduto, P. W., Berkey, B., Gaspar, L. E., Mehta, M., & Curran, W. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citationSperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J., Roberge, D., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 985
Self-citationBorgelt, B., Gelber, R., Kramer, S., Brady, L. W., Chang, C. H., Davis, L. W., Perez, C. A., & Hendrickson, F. R. (1980) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(80)90195-9 · Cited by 953
Wilkinson, E. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951
Mintz, A. H., Kestle, J. R. W., Rathbone, M. P., Gaspar, L. E., Hugenholtz, H., Fisher, B., Duncan, G. G., Skingley, P., Foster, G., & Levine, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961001)78:7<1470::aid-cncr14>3.0.co;2-x · Cited by 685
Self-citationSurgical treatment of multiple brain metastases
Bindal, R. K., Sawaya, R., Leavens, M. E., & Lee, J. J. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.79.2.0210 · Cited by 561
Aoyama, H., Tago, M., Kato, N., Toyoda, T., Kenjyo, M., Hirota, S., Shioura, H., Inomata, T., Kunieda, E., Hayakawa, K., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.048 · Cited by 545
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 529
Self-citationLinskey, M. E., Andrews, D. W., Asher, A. L., Burri, S. H., Kondziolka, D., Robinson, P. D., Ammirati, M., Cobbs, C. S., Gaspar, L. E., Loeffler, J. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0073-4 · Cited by 507
Self-citationKalkanis, S. N., Kondziolka, D., Gaspar, L. E., Burri, S. H., Asher, A. L., Cobbs, C. S., Ammirati, M., Robinson, P. D., Andrews, D. W., Loeffler, J. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0061-8 · Cited by 412
Self-citationRyken, T. C., McDermott, M., Robinson, P. D., Ammirati, M., Andrews, D. W., Asher, A. L., Burri, S. H., Cobbs, C. S., Gaspar, L. E., Kondziolka, D., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0057-4 · Cited by 363
Self-citationMehta, M. P., Tsao, M. N., Whelan, T. J., Morris, D. E., Hayman, J. A., Flickinger, J. C., Mills, M., Rogers, C. L., & Souhami, L. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.023 · Cited by 346
Self-citationMuacevic, A., Wowra, B., Siefert, A., Tonn, J.-C., Steiger, H.-J., & Kreth, F. W. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9510-4 · Cited by 344
Antonadou, D., Paraskevaidis, M., Sarris, G., Coliarakis, N., Economou, I., Karageorgis, P., & Throuvalas, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.140 · Cited by 331
Kurtz, J. M., Gelber, R., Brady, L. W., Carella, R. J., & Cooper, J. S. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90005-5 · Cited by 331
Murray, K. J., Scott, C., Greenberg, H. M., Emami, B., Seider, M., Vora, N. L., Olson, C., Whitton, A., Movsas, B., & Curran, W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00341-6 · Cited by 314
Gaspar, L. E., Mehta, M. P., Patchell, R. A., Burri, S. H., Robinson, P. D., Morris, R. E., Ammirati, M., Andrews, D. W., Asher, A. L., Cobbs, C. S., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0060-9 · Cited by 299
Self-citationRobinet, G., Thomas, P., Breton, J. L., Léna, H., Gouva, S., Dabouis, G., Bennouna, J., Souquet, P. J., Balmes, P., Thiberville, L., et al. (2001) · Annals of Oncology · doi:10.1023/a:1008338312647 · Cited by 264
T.Komarnicky, L., Phillips, T. L., Martz, K., Asbell, S., Isaacson, S., & Urtasun, R. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90137-s · Cited by 237
Phillips, T. L., Scott, C. B., Leibel, S. A., Rotman, M., & Weigensberg, I. J. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00168-x · Cited by 185
Priestman, T. J., Dunn, J., Brada, M., Rampling, R., & Baker, P. G. (1996) · Clinical Oncology · doi:10.1016/s0936-6555(05)80717-4 · Cited by 171
Mehta, M. P., Shapiro, W. R., Phan, S. C., Gervais, R., Carrie, C., Chabot, P., Patchell, R. A., Glantz, M. J., Recht, L., Langer, C., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.068 · Cited by 164
Mehta, M. P., Paleologos, N. A., Mikkelsen, T., Robinson, P. D., Ammirati, M., Andrews, D. W., Asher, A. L., Burri, S. H., Cobbs, C., Gaspar, L. E., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0062-7 · Cited by 155
Self-citationLee, D. H., Han, J., Kim, H. T., Yoon, S. J., Pyo, H. R., Cho, K. H., Shin, S., Yoo, H., Lee, S. H., & Lee, J. S. (2008) · Cancer · doi:10.1002/cncr.23526 · Cited by 101
Neuhaus, T., Ko, Y., Müller, R.-P., Grabenbauer, G. G., Hedde, J.-P., Schueller, H., Köcher, M., Stier, S., & Fietkau, R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604835 · Cited by 99
Chemotherapy of brain metastases from lung carcinoma
Ushio, Y., Arita, N., Hayakawa, T., et al. (1991) · Neurosurgery · doi:10.1097/00006123-199102000-00005 · Cited by 98
Serizawa, T., Hirai, T., Nagano, O., Higuchi, Y., Matsuda, S., Ono, J., & Saeki, N. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0169-x · Cited by 97
Knisely, J. P. S., Berkey, B. A., Chakravarti, A., Yung, A. W. K., Curran, W. J., Robins, H. I., Movsas, B., Brachman, D. G., Henderson, R. H., & Mehta, M. P. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.09.016 · Cited by 93
Chemotherapy of Brain Metastases from Lung Carcinoma: A Controlled Randomized Study
Ushio, Y., Arita, N., Hayakawa, T., et al. (1991) · Neurosurgery · doi:10.1227/00006123-199102000-00005 · Cited by 91
The combined use of radiation therapy and lonidamine in the treatment of brain metastases
DeAngelis, L., Currie, V. E., Kim, J. H., et al. (1989) · Journal of Neuro-Oncology · doi:10.1007/bf00172917 · Cited by 80
Scott, C., Suh, J. H., Stea, B., Nabid, A., & Hackman, J. (2007) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3180653c0d · Cited by 75
Roos, D. E., Smith, J., & Stephens, S. (2011) · Clinical Oncology · doi:10.1016/j.clon.2011.04.009 · Cited by 70
Brain Metastasis from an Unknown Primary, or Primary Brain Tumour? A Diagnostic Dilemma
Campos, S., Davey, P., Hird, A. E., Pressnail, B., Bilbao, J. M., Aviv, R. I., Symons, S. P., Pirouzmand, F., Sinclair, E., Culleton, S., et al. (2009) · Current Oncology · doi:10.3747/co.v16i1.308 · Cited by 66
Eyre, H., Ohlsen, J., Frank, J., et al. (1984) · Journal of Neuro-Oncology · doi:10.1007/bf00178115 · Cited by 61
Cited by
Yamamoto, M., Serizawa, T., Shuto, T., Akabane, A., Higuchi, Y., Kawagishi, J., Yamanaka, K., Sato, Y., Jokura, H., Yomo, S., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70061-0 · Cited by 1,447
CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
Lin, N. U., Amiri-Kordestani, L., Palmieri, D., Liewehr, D. J., & Steeg, P. S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0790 · Cited by 1,286
Gondi, V., Pugh, S. L., Tome, W. A., Caine, C., Corn, B., Kanner, A., Rowley, H., Kundapur, V., DeNittis, A., Greenspoon, J. N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2909 · Cited by 1,148
Current approaches to the management of brain metastases
Suh, J. H., Kotecha, R., Chao, S. T., Ahluwalia, M. S., Sahgal, A., & Chang, E. L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0320-3 · Cited by 553
Self-citationSperduto, P. W., Mesko, S., Li, J., Cagney, D., Aizer, A., Lin, N. U., Nesbit, E., Kruser, T. J., Chan, J., Braunstein, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01255 · Cited by 471
Self-citation
Metadata
- Authors
- Tsao, M. N., Rades, D., Wirth, A., Lo, S. S., Danielson, B. L., Gaspar, L. E., Sperduto, P. W., Vogelbaum, M. A., Radawski, J. D., Wang, J. Z., Gillin, M. T., Mohideen, N., Hahn, C. A., & Chang, E. L.
- Venue
- Practical Radiation Oncology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 2
- Issue
- 3
- Pages
- 210-225
- ISSN
- 1879-8500 (ISSN-L)
- OpenAlex
- W2162887147
- Cited by
- 587
- References
- 42
- FWCI
- 32.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.